BR9507517A - Derivados de benzocicloalquilazotetiona - Google Patents
Derivados de benzocicloalquilazotetionaInfo
- Publication number
- BR9507517A BR9507517A BR9507517A BR9507517A BR9507517A BR 9507517 A BR9507517 A BR 9507517A BR 9507517 A BR9507517 A BR 9507517A BR 9507517 A BR9507517 A BR 9507517A BR 9507517 A BR9507517 A BR 9507517A
- Authority
- BR
- Brazil
- Prior art keywords
- thioxo
- dihydro
- benzocycloalkylazolethione
- triazol
- substituents
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/32—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/32—One oxygen atom
- C07D233/36—One oxygen atom with hydrocarbon radicals, substituted by nitrogen atoms, attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/42—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Lubricants (AREA)
- Plural Heterocyclic Compounds (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Luminescent Compositions (AREA)
- Polarising Elements (AREA)
- Paints Or Removers (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Preventing Corrosion Or Incrustation Of Metals (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Detergent Compositions (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23383594A | 1994-04-26 | 1994-04-26 | |
US08/233,655 US5438150A (en) | 1994-04-26 | 1994-04-26 | Process for making 1-benzocycloalkyl-1,3-dihydroimidazole-2-thione derivatives |
US08/403,209 US5538988A (en) | 1994-04-26 | 1995-03-17 | Benzocycloalkylazolethione derivatives |
PCT/US1995/004783 WO1995029165A2 (en) | 1994-04-26 | 1995-04-25 | Benzocycloalkylaz0lethione derivatives as dopamin beta-hydroxylase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9507517A true BR9507517A (pt) | 1997-09-16 |
Family
ID=27398461
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9507517A BR9507517A (pt) | 1994-04-26 | 1995-04-25 | Derivados de benzocicloalquilazotetiona |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP0757677B1 (pt) |
JP (1) | JPH09512269A (pt) |
CN (1) | CN1113874C (pt) |
AT (1) | ATE243199T1 (pt) |
AU (1) | AU687192B2 (pt) |
BR (1) | BR9507517A (pt) |
CA (1) | CA2188748A1 (pt) |
CZ (1) | CZ290082B6 (pt) |
DE (1) | DE69531102T2 (pt) |
DK (1) | DK0757677T3 (pt) |
ES (1) | ES2201104T3 (pt) |
FI (1) | FI964312A (pt) |
HU (1) | HUT76295A (pt) |
IL (1) | IL113480A (pt) |
MX (1) | MX9605145A (pt) |
NO (1) | NO311720B1 (pt) |
NZ (1) | NZ284356A (pt) |
PL (1) | PL185959B1 (pt) |
PT (1) | PT757677E (pt) |
RU (1) | RU2145321C1 (pt) |
WO (1) | WO1995029165A2 (pt) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6479484B1 (en) | 1997-11-21 | 2002-11-12 | Euro-Celtique S.A. | Substituted 2-aminoacetamides and the use thereof |
WO1999040063A1 (fr) * | 1998-02-06 | 1999-08-12 | Yoshitomi Pharmaceutical Industries, Ltd. | Nouveaux derives de l'acide hydroxamique de type azapeptide |
JP4978762B2 (ja) * | 2001-03-30 | 2012-07-18 | Dic株式会社 | シクロヘキサ−3−エン−1−オール誘導体の製造方法 |
US7125904B2 (en) * | 2002-10-11 | 2006-10-24 | Portela & C.A., S.A. | Peripherally-selective inhibitors of dopamine-β-hydroxylase and method of their preparation |
GB2393958A (en) * | 2002-10-11 | 2004-04-14 | Portela & Ca Sa | Peripherally-selective imidazole inhibitors of dopamine-beta-hydroxylase |
GB0600709D0 (en) * | 2006-01-13 | 2006-02-22 | Portela & Ca Sa | Drug combinations |
JP5372771B2 (ja) | 2006-12-12 | 2013-12-18 | ビアル−ポルテア アンド シー.エイ., エス.エイ. | プロセス |
EP2121668A2 (en) * | 2007-02-01 | 2009-11-25 | BIAL - Portela & Ca., S.A. | 6,8-dichlorchroman-3-yl-1,3-dihydroimidazole-2-thione derivatives and their use for the treatment of cardiovascular disorders |
EP1977646A1 (en) * | 2007-04-03 | 2008-10-08 | Bayer CropScience AG | Insecticidal hydroxyethyl thlourea derivatives |
GB0708818D0 (en) * | 2007-05-08 | 2007-06-13 | Portela & Ca Sa | Compounds |
GB0709695D0 (en) * | 2007-05-21 | 2007-06-27 | Portela & Ca Sa | Process |
TW200927740A (en) * | 2007-11-13 | 2009-07-01 | Bial Portela & Ca Sa | Process |
ES2667099T3 (es) | 2011-06-29 | 2018-05-09 | Bial-Portela & Ca, S.A. | Procedimiento |
SI2919780T1 (sl) * | 2012-11-14 | 2018-12-31 | Bial - Portela & Ca., S.A. | Derivati 1,3-dihidroimidazol-2-tiona za uporabo v zdravljenju pljučne arterijske hipertenzije in poškodbe pljuč |
WO2018022823A1 (en) * | 2016-07-28 | 2018-02-01 | Asieris Pharmaceutical Technologies Co., Ltd. | Uses of dopamine beta-hydroxylase (dbh) inhibitors and serotonin receptor (5-ht) antagonists for the treatment of cancer |
JOP20190050A1 (ar) | 2016-09-23 | 2019-03-20 | Bial Portela & C? S A | مثبطات دوبامين-b-هيدروكسيلاز تخترق حاجز المخ الدموي |
US11434242B2 (en) | 2017-12-04 | 2022-09-06 | Bial—Portela & Ca, S.A. | Dopamine-b-hydroxylase inhibitors |
GB201908044D0 (en) | 2019-06-05 | 2019-07-17 | Bial Portela & Ca Sa | Dopamine-B-Hydroxylase inhibitors |
WO2022161364A1 (zh) | 2021-01-26 | 2022-08-04 | 江苏亚虹医药科技股份有限公司 | 通路调节剂、含其的药物组合物、其用途和采用其的治疗方法 |
CN113527108B (zh) * | 2021-09-16 | 2022-10-25 | 斯芬克司药物研发(天津)股份有限公司 | 一种制备光学纯的5,7-二氟-1,2,3,4-四氢化萘-2-胺及其盐的方法 |
CN114920906B (zh) * | 2022-05-23 | 2023-03-21 | 华南理工大学 | 一种含咪唑硫酮单元的聚氨酯及其制备方法和应用 |
WO2024056079A1 (zh) * | 2022-09-16 | 2024-03-21 | 江苏亚虹医药科技股份有限公司 | 内匹司他酸加成盐的多晶型及其制备方法和用途 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3485917A (en) * | 1966-04-14 | 1969-12-23 | Janssen Pharmaceutica Nv | Composition and method for combating fungus with imidazole carboxylates |
GB8516573D0 (en) * | 1985-07-01 | 1985-08-07 | Janssen Pharmaceuticaa Nv | Controlling weeds |
EP0277384A3 (en) * | 1986-12-24 | 1990-05-23 | Janssen Pharmaceutica N.V. | 1h-imidazole-5-carboxylic acid derivatives |
-
1995
- 1995-04-25 PT PT95916449T patent/PT757677E/pt unknown
- 1995-04-25 CN CN95193567A patent/CN1113874C/zh not_active Expired - Fee Related
- 1995-04-25 EP EP95916449A patent/EP0757677B1/en not_active Expired - Lifetime
- 1995-04-25 HU HU9602946A patent/HUT76295A/hu unknown
- 1995-04-25 DK DK95916449T patent/DK0757677T3/da active
- 1995-04-25 RU RU96122779/04A patent/RU2145321C1/ru not_active IP Right Cessation
- 1995-04-25 MX MX9605145A patent/MX9605145A/es unknown
- 1995-04-25 PL PL95316856A patent/PL185959B1/pl not_active IP Right Cessation
- 1995-04-25 ES ES95916449T patent/ES2201104T3/es not_active Expired - Lifetime
- 1995-04-25 AU AU22947/95A patent/AU687192B2/en not_active Ceased
- 1995-04-25 CA CA002188748A patent/CA2188748A1/en not_active Abandoned
- 1995-04-25 IL IL11348095A patent/IL113480A/xx not_active IP Right Cessation
- 1995-04-25 CZ CZ19963109A patent/CZ290082B6/cs not_active IP Right Cessation
- 1995-04-25 AT AT95916449T patent/ATE243199T1/de not_active IP Right Cessation
- 1995-04-25 DE DE69531102T patent/DE69531102T2/de not_active Expired - Fee Related
- 1995-04-25 BR BR9507517A patent/BR9507517A/pt not_active IP Right Cessation
- 1995-04-25 WO PCT/US1995/004783 patent/WO1995029165A2/en active Application Filing
- 1995-04-25 JP JP7527727A patent/JPH09512269A/ja not_active Ceased
- 1995-04-25 NZ NZ284356A patent/NZ284356A/en unknown
-
1996
- 1996-10-25 FI FI964312A patent/FI964312A/fi not_active IP Right Cessation
- 1996-10-25 NO NO19964552A patent/NO311720B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO311720B1 (no) | 2002-01-14 |
AU687192B2 (en) | 1998-02-19 |
IL113480A (en) | 2000-06-29 |
PL185959B1 (pl) | 2003-09-30 |
HUT76295A (en) | 1997-07-28 |
PT757677E (pt) | 2003-11-28 |
CZ290082B6 (cs) | 2002-05-15 |
CZ310996A3 (en) | 1997-06-11 |
WO1995029165A2 (en) | 1995-11-02 |
WO1995029165A3 (en) | 1995-12-07 |
DE69531102T2 (de) | 2004-04-29 |
AU2294795A (en) | 1995-11-16 |
FI964312A0 (fi) | 1996-10-25 |
CN1151735A (zh) | 1997-06-11 |
NO964552D0 (no) | 1996-10-25 |
PL316856A1 (en) | 1997-02-17 |
ATE243199T1 (de) | 2003-07-15 |
CA2188748A1 (en) | 1995-11-02 |
CN1113874C (zh) | 2003-07-09 |
DK0757677T3 (da) | 2003-10-13 |
NO964552L (no) | 1996-12-27 |
NZ284356A (en) | 1997-12-19 |
MX9605145A (es) | 1997-12-31 |
FI964312A (fi) | 1996-12-20 |
HU9602946D0 (en) | 1996-12-30 |
RU2145321C1 (ru) | 2000-02-10 |
EP0757677A1 (en) | 1997-02-12 |
ES2201104T3 (es) | 2004-03-16 |
IL113480A0 (en) | 1995-07-31 |
JPH09512269A (ja) | 1997-12-09 |
EP0757677B1 (en) | 2003-06-18 |
DE69531102D1 (de) | 2003-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9507517A (pt) | Derivados de benzocicloalquilazotetiona | |
ES2160949T3 (es) | Derivados de fenilen-sulfonamida sustituidos en meta. | |
KR950017957A (ko) | 3, 4, 4-삼치환-피페리디닐-n-알킬카르복실레이트의 제법 및 중간체 | |
IL99759A (en) | Mono-fluorinated derivatives of n-propargyl-1-aminoindan, their preparation and pharmaceutical compositions containing them | |
DE69831868D1 (en) | Antithrombosemittel | |
DK0889875T3 (da) | Cycloproylalkansyrederivater | |
CA2113229A1 (en) | Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof | |
AU4264396A (en) | Cosmetic or pharmaceutical compositions containing mangiferin or derivatives thereof | |
ES2164763T3 (es) | Composiciones para el aclaramiento de la piel. | |
IL133623A0 (en) | Antithrombotic agents | |
ES2150489T3 (es) | 1-amidinofenil-pirrolidonas, -piperidinonas, -azetinonas como inhibidores de la agregacion de plaquetas. | |
BR9908545A (pt) | Derivado de piperidina, processo para a preparação do mesmo, composto, processo para a preparação do mesmo, e, composição farmacêutica | |
CA2073686A1 (en) | N,n'-dihaloimidazolidin-4-ones | |
ATE109787T1 (de) | Latente alkylierungsubstituenten enthaltende anthracycline-analoge. | |
ES2108422T3 (es) | Combinaciones sinergicas de productos antisolares y composiciones cosmeticas y dermatologicas que las contienen. | |
MX9805023A (es) | Derivados de 1-metilcarbapenem. | |
UA27108A1 (uk) | Аhтрацикліhові глікозиди та їх фармацевтичhо прийhятhі кислотhо-адитивhі солі, спосіб їх одержаhhя, похідhі 1,6-дийод-3-оксапеhтаhу та спосіб їх одержаhhя | |
EP0645382A4 (en) | CUMARIN DERIVATIVES AND THEIR USE. | |
HU9503775D0 (en) | Benzene derivative useful for ischemic diseases | |
AR004949A1 (es) | Derivados de benzoil-4-pirazol, procedimiento para obtenerlos, composiciones herbicidas que los contienen y procedimientos para combatirplantas indeseables. | |
RU94044457A (ru) | Применение бензтиофенов для ингибирования гирсутизма и алопеции у женщин | |
CA2052020A1 (en) | Pradimicin derivatives | |
NO20004685L (no) | Nye forbindelser | |
DE69528984D1 (de) | Hemmung der leukotrienbiosynthese mittels harnstoffderivaten | |
ES8605819A1 (es) | Procedimiento de preparacion de nuevos derivados nucleosidos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB36 | Technical and formal requirements: requirement - article 36 of industrial property law | ||
FB36 | Technical and formal requirements: requirement - article 36 of industrial property law | ||
HJEG | Technical examination (opinion): technical examination (opinion) related to article 229 of industrial property law | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B25A | Requested transfer of rights approved |
Free format text: SYNTEX (U.S.A.) LLC (US) |
|
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] | ||
B24C | Patent annual fee: request for for restoration |
Free format text: REFERENTE A 11A,12A,13A,14A,15A E 16A ANUIDADES |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE AS 16A, 17A, 18A, 19A E 20A ANUIDADES. PAGAR RESTAURACAO. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |